{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:42:07Z","timestamp":1790811727119,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS117912"],"award-info":[{"award-number":["R01NS117912"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI136514"],"award-info":[{"award-number":["R01AI136514"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI169085"],"award-info":[{"award-number":["R21AI169085"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI150747"],"award-info":[{"award-number":["U01AI150747"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01NS047726"],"award-info":[{"award-number":["R01NS047726"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01HL061322"],"award-info":[{"award-number":["R01HL061322"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P50AR052646"],"award-info":[{"award-number":["P50AR052646"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01NS120060"],"award-info":[{"award-number":["R01NS120060"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015273","name":"Petroleum Technology Alliance Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.omtm.2024.101349","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T19:07:51Z","timestamp":1727723271000},"page":"101349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Single cell and TCR analysis of immune cells from AAV gene therapy-dosed Duchenne muscular dystrophy patients"],"prefix":"10.1016","volume":"32","author":[{"given":"Michael R.","family":"Emami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Brimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence O.","family":"Whiteley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Casinghino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Lanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip K.","family":"Farahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney S.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"McNally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Armando","family":"Villalta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan A.","family":"Schattgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7104-544X","authenticated-orcid":false,"given":"Melissa J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101349_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0302-253","article-title":"Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy","volume":"8","author":"Harper","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2024.101349_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2024.101349_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173510","article-title":"Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies","volume":"134","author":"Salabarria","year":"2024","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101349_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1001263","article-title":"Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2024.101349_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1001263","article-title":"rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2024.101349_bib6","first-page":"42","article-title":"[Thrombotic Microangiopathy (TMA) after Gene Replacemant Therapy (GRT) due to Spinal Muscular Atrophy: Case Summary and Recommendations for Treatment]","volume":"234","author":"Witte","year":"2022","journal-title":"Klin. P\u00e4diatr."},{"key":"10.1016\/j.omtm.2024.101349_bib7","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/JVI.01990-07","article-title":"Complement is an essential component of the immune response to adeno-associated virus vectors","volume":"82","author":"Zaiss","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101349_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1084\/jem.173.1.55","article-title":"Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19","volume":"173","author":"Matsumoto","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2024.101349_bib9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.173.5.1083","article-title":"Molecular interactions of complement receptors on B lymphocytes: a CR1\/CR2 complex distinct from the CR2\/CD19 complex","volume":"173","author":"Tuveson","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2024.101349_bib10","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1073\/pnas.93.8.3357","article-title":"Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2","volume":"93","author":"Molina","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2024.101349_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1074-7613(00)80433-1","article-title":"Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen","volume":"4","author":"Ahearn","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.omtm.2024.101349_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nm0402-373","article-title":"Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection","volume":"8","author":"Kopf","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2024.101349_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.999021","article-title":"Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood","volume":"13","author":"Smith","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2024.101349_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.omtm.2023.06.002","article-title":"Innate and adaptive AAV-mediated immune responses in a mouse model of Duchenne muscular dystrophy","volume":"30","author":"Emami","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101349_bib15","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMc2212912","article-title":"Dystrophin Immunity after Gene Therapy for Duchenne's Muscular Dystrophy","volume":"388","author":"Bonnemann","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2024.101349_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101349_bib17","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2024.101349_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/v11111020","article-title":"Emerging Role of LY6E in Virus-Host Interactions","volume":"11","author":"Yu","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.omtm.2024.101349_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3389\/fimmu.2019.00819","article-title":"Emerging Role of Lymphocyte Antigen-6 Family of Genes in Cancer and Immune Cells","volume":"10","author":"Upadhyay","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2024.101349_bib20","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1172\/JCI31184","article-title":"LAG-3 regulates CD8+ T\u00a0cell accumulation and effector function in murine self- and tumor-tolerance systems","volume":"117","author":"Grosso","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101349_bib21","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/ecco-jcc\/jjaa054","article-title":"Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis","volume":"14","author":"Slevin","year":"2020","journal-title":"J.\u00a0Crohns Colitis"},{"key":"10.1016\/j.omtm.2024.101349_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltab025","article-title":"Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity","volume":"2","author":"Burnell","year":"2022","journal-title":"Immunother. Adv."},{"key":"10.1016\/j.omtm.2024.101349_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41587-021-00989-2","article-title":"Integrating T\u00a0cell receptor sequences and transcriptional profiles by clonotype neighbor graph analysis (CoNGA)","volume":"40","author":"Schattgen","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101349_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature22383","article-title":"Quantifiable predictive features define epitope-specific T\u00a0cell receptor repertoires","volume":"547","author":"Dash","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2024.101349_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68605","article-title":"TCR meta-clonotypes for biomarker discovery with tcrdist3 enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs","volume":"10","author":"Mayer-Blackwell","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.omtm.2024.101349_bib26","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1212\/WNL.0000000000203462","article-title":"Long-term Safety and Efficacy in Patients with DMD 4 Years Post-Treatment with Delandistrogene Moxeparvovec (SRP-9001) in a Phase 1\/2a Study (P3-8.006)","volume":"100","author":"Mendell","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2024.101349_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JND-221639","article-title":"Meeting Report: 2022 Muscular Dystrophy Association Summit on \u2018Safety and Challenges in Gene Transfer Therapy\u2019","volume":"10","author":"Lek","year":"2023","journal-title":"J.\u00a0Neuromuscul. Dis."},{"key":"10.1016\/j.omtm.2024.101349_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.634937","article-title":"The Functional and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene Expression","volume":"12","author":"Sajid","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2024.101349_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01159-19","article-title":"Novel Functions of IFI44L as a Feedback Regulator of Host Antiviral Responses","volume":"93","author":"DeDiego","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101349_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00209-18","article-title":"The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins","volume":"3","author":"Weiss","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.omtm.2024.101349_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084095","article-title":"STAT1 and Its Crucial Role in the Control of Viral Infections","volume":"23","author":"Tolomeo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2024.101349_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/MMBR.00024-13","article-title":"Mx proteins: antiviral gatekeepers that restrain the uninvited","volume":"77","author":"Verhelst","year":"2013","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.omtm.2024.101349_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081864","article-title":"TRIM22. A Multitasking Antiviral Factor","volume":"10","author":"Pagani","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2024.101349_bib34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/CDLI.7.6.859-864.2000","article-title":"New methods for assessing T-cell responses","volume":"7","author":"Bercovici","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.omtm.2024.101349_bib35","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1158\/1078-0432.CCR-08-0846","article-title":"Gene expression profiling reveals similarities between the in\u00a0vitro and in\u00a0vivo responses of immune effector cells to IFN-alpha","volume":"14","author":"Zimmerer","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtm.2024.101349_bib36","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.cell.2020.10.001","article-title":"Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19","volume":"183","author":"Meckiff","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2024.101349_bib37","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.3389\/fimmu.2019.02568","article-title":"Gene Expression-Based Identification of Antigen-Responsive CD8(+) T Cells on a Single-Cell Level","volume":"10","author":"Fuchs","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2024.101349_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtm.2024.101349_bib39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41421-021-00300-2","article-title":"Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization","volume":"7","author":"Cao","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.omtm.2024.101349_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1034159","article-title":"Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T\u00a0cell activation in the COVID-19 positive and recovered individuals","volume":"13","author":"Chattopadhyay","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2024.101349_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omtm.2024.101349_bib42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03569-1","article-title":"A molecular single-cell lung atlas of lethal COVID-19","volume":"595","author":"Melms","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2024.101349_bib43","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","article-title":"Single-cell multi-omics analysis of the immune response in COVID-19","volume":"27","author":"Stephenson","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2024.101349_bib44","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1002\/jmv.28012","article-title":"Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection","volume":"94","author":"Wang","year":"2022","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.omtm.2024.101349_bib45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.immuni.2020.07.009","article-title":"Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients","volume":"53","author":"Zhu","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.omtm.2024.101349_bib46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajh.20068","article-title":"Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation","volume":"76","author":"Belford","year":"2004","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.omtm.2024.101349_bib47","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.bmt.1702003","article-title":"Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children","volume":"24","author":"Matsuda","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omtm.2024.101349_bib48","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/tri.12582","article-title":"Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature","volume":"28","author":"Java","year":"2015","journal-title":"Transpl. Int."},{"key":"10.1016\/j.omtm.2024.101349_bib49","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/hum.2013.092","article-title":"Anti-dystrophin T\u00a0cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect","volume":"24","author":"Flanigan","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101349_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12688\/f1000research.22139.1","article-title":"scRepertoire: An R-based toolkit for single-cell immune receptor analysis","volume":"9","author":"Borcherding","year":"2020","journal-title":"F1000Res."},{"key":"10.1016\/j.omtm.2024.101349_bib51","first-page":"e1","article-title":"Improving health-related quality of life instrument translation into South African languages","volume":"63","author":"Marsh","year":"2021","journal-title":"S.\u00a0Afr. Fam. Pract."},{"key":"10.1016\/j.omtm.2024.101349_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx356","article-title":"WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:55:59Z","timestamp":1778867759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050124001657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2329050124001657"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101349","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single cell and TCR analysis of immune cells from AAV gene therapy-dosed Duchenne muscular dystrophy patients","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101349"}}